Insulinanaloga: Struktur, Eigenschaften und therapeutische Indikationen
- 1 December 2001
- journal article
- research article
- Published by Springer Nature in Die Innere Medizin
- Vol. 42 (12), 1692-1699
- https://doi.org/10.1007/s001080170022
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptorNature Medicine, 1999
- Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pensThe Lancet, 1999
- Insulin analogues and their potential in the management of diabetes mellitusDiabetologia, 1999
- Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes MellitusAnnals of Internal Medicine, 1999
- Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.Diabetes Care, 1999
- Insulin analogs with improved pharmacokinetic profilesAdvanced Drug Delivery Reviews, 1999
- Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.Diabetes Care, 1998
- Effect of Continuous Subcutaneous Insulin Infusion With Lispro on Hepatic Responsiveness to Glucagon in Type 1 DiabetesDiabetes Care, 1998
- Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-mealDiabetic Medicine, 1998
- Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathyBritish Journal of Ophthalmology, 1998